InvivoSciences, inc.

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
InvivoSciences, Inc. (IVS) develops personalized Micro-Organs for Improving Human Health. Our vision is to transform Biopharmaceutical companies into safe and effective precision medicine providers for patients in a wide range of therapeutic areas including cardiac, cancer and rare diseases. IVS provides patented, automated human organ-on-a-chip predictive assay technology platforms for drug development to its partners. We offer phenotypic analysis using our personalized organotypic human samples for accurate prediction of patient-specific safety and efficacy of drug candidates for the pre-clinical development of personalized biopharmaceutical products and their safety analysis. We can test therapeutics in populations with specific genetic polymorphisms and genotypes for cardiovascular disorders and we can also perform reliable toxicity screening rapidly, accurately and cost-effectively. Our 3D- Human Micro-Tissue Technologies accelerates cardio-safe Personalized Drug Discovery and
Company Type:
Company Website:
Company HQ State:
Wisconsin
Company HQ Country:
United States
Year Founded:
2001
Main Therapeutic Focus:
Lead Product in Development:
NuHeart TM cardiac human tissue model, cardiac disease models, automated tissue based drug screening
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
6
Speaker
photo
CEO/President
InvivoSciences, Inc.